In the past year, Bayer Healthcare has come under increasing fire for the marketing and distribution of Essure, a birth control implant which has allegedly caused more than 300 fetal deaths and has been the subject of more than 16,000 complaints since it entered the market over a decade ago.
The Food and Drug Administration is investigating the contraceptive and members of Congress have voiced concerns, amid claims that the device has caused users extreme pain and is less effective in preventing pregnancies as advertised. Now a Connecticut woman, April Norman, who underwent a hysterectomy in order to have her Essure removed has joined has joined in the litigation against Bayer. Her seven-count suit, filed Feb. 16 in U.S. District Court, claims that Bayer failed to notify consumers of the potential side-effects, was negligent in training doctors how to implant the device, and fraudulently concealed the problems with the contraceptive and the complaints made about it.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
